The ARMS2 gene is active in the retina, the light sensitive tissue at the back of the eye, and is thought to help support the macula, which gives you sharp central vision. Certain variants near or in the ARMS2 gene are linked to a higher chance of age-related macular degeneration, so some people may notice blurred or distorted central vision as they get older. These variants influence risk rather than guarantee disease, and age and smoking also play a role.
What is a gene?
A gene is a stretch of DNA that carries information your cells use to make molecules or regulate processes in the body. Some genes provide the instructions for making proteins, the parts of cells that do the work. Other genes mainly help direct when certain processes happen, where they take place, and how strongly they run. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
ARMS2Gene function
What if the gene works
The ARMS2 gene is active in the retina, the light sensing tissue at the back of the eye. It appears to help retinal cells handle normal stress and may support sharp central vision.
Risk
What if the gene does not work
Variants in the ARMS2 gene are linked to age-related macular degeneration, which can blur vision and make reading or face recognition harder. Effects range from milder to stronger variants that may influence if AMD develops and how advanced it becomes.
Treatment
What does that mean for your treatment
For the ARMS2 gene, no treatment approach or drug choice based on this gene is currently established in clinical guidelines. ARMS2 variants are being studied as biomarkers in age related macular degeneration, including possible links to response to anti-VEGF eye treatment and vitamin supplements, but this has not led to routine gene guided care.
Gene function
What if the gene works
Sharp central vision depends on steady support from cells at the back of the eye. In the retina, the ARMS2 gene is especially relevant in areas that support detailed sight. Understanding ARMS2 gene function in the retina helps explain how this tissue stays clear and well maintained during everyday visual activity.
In the macula, the ARMS2 gene supports routine maintenance in the part of the retina that helps you read, drive, and see detail. Its protein is linked to the routine cleanup and upkeep this high demand area needs each day.
In retinal support tissue, the ARMS2 gene is linked to handling worn out material produced during normal cell activity. This cleanup supports a healthier space beneath the retina, where nutrients and waste move back and forth.
Beneath the retina, the ARMS2 gene is linked to maintaining the local environment where light sensing cells meet their support layers. This steady setting helps those cells carry out their daily work.
What is a variant?
Within a gene, a genetic variant is a small difference in the DNA sequence. These changes are common and help create normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change gene function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many ARMS2 gene variants linked to age related macular degeneration appear to change how stable the gene’s RNA message is, so cells may make less ARMS2 protein. Some, including common changes near or within the ARMS2 gene, may also affect protein folding or where the protein ends up inside the cell. ARMS2 gene variants can range from milder changes with small effects to more disruptive ones that more clearly reduce gene output, which may influence how strongly risk is raised.
How variants are linked to conditions
Variants in the ARMS2 gene are strongly linked to age-related macular degeneration, a common cause of central vision loss in older adults. Research on the ARMS2 gene and age-related macular degeneration risk shows that some common variants are associated with a higher chance of developing the condition, especially its later forms. These findings describe risk, not certainty, so many people with a variant in the ARMS2 gene never develop macular degeneration.
A variant is not necessarily a diagnosis
Variants in genes are a usual feature of human biology and are widely found across the population. Most do not directly affect health and instead represent normal human variation. For many genes, having a variant associated with a condition points to a potential link, not a certain diagnosis, particularly when several genes and environmental influences play a role. Still, in some situations, one well understood variant in a particular gene is enough to establish a diagnosis.
Are there things that can increase or change my risk?
For ARMS2, the clearest risk changes are for age-related macular degeneration, an eye condition that can affect central vision. Risk is higher with older age, smoking, and a family history of the condition, and some may also have higher risk when ARMS2 changes occur alongside certain changes in other genes, such as CFH.
Inheritance of ARMS2 variants
There is not a single, broadly confirmed Mendelian pattern for how ARMS2 gene variants are inherited, because ARMS2 is mainly linked to age related macular degeneration risk rather than to a condition caused by one variant alone. In practice, how ARMS2 gene variants are inherited follows the usual pattern for genes on the numbered chromosomes: you receive one copy from each parent. The ARMS2 gene is located on chromosome 10, which is an autosome, so variants can be passed to children of any sex.
What does my ARMS2 result mean for my family?
There is not a broadly confirmed single-gene inheritance pattern for ARMS2 tied to a specific inherited condition. Changes in ARMS2 are better understood as affecting the chance of age-related macular degeneration rather than causing it on their own, so a result does not clearly predict what it means for relatives.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the ARMS2 gene usually uses a saliva or blood sample, and ARMS2 genetic testing for age-related macular degeneration risk looks for specific DNA changes in a lab. Results can show whether you carry a linked risk variant, but they do not predict with certainty whether vision loss will happen.
When should I consider getting a genetic test?
There isn't yet a broadly established ARMS2-specific reason for genetic testing in routine care. Decisions about testing are best made with a doctor or genetic counselor, based on your eye health and family history of age-related macular degeneration.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they explain varies with the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can influence how people respond to medicines. Small differences in DNA can affect how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same treatment may work well for one person, work less well for another, or cause more side effects in some people.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It looks at relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body handles it. Understanding this can support more informed and more individualized treatment choices. You can read more about this topic in the LearnHub.
Drugs influenced by the ARMS2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or used, so general concerns about treatment or side effects are best discussed with your doctor. ARMS2 has been studied in people with age-related macular degeneration to see whether it affects response to eye treatments, but those findings are not used as standard prescribing guidance.
History
Interest in the ARMS2 gene grew as researchers tried to explain why some families had a higher chance of age related macular degeneration, a common cause of central vision loss in later life. In recent decades, awareness of this gene’s role has grown. In the mid 2000s, studies of a region on chromosome 10 pointed to the ARMS2 gene as an important genetic marker linked to this eye condition. Researchers then debated whether ARMS2, a nearby gene called HTRA1, or both were driving the signal seen in genetic studies. Over time, descriptions became more precise. This work helped shape modern genetic research on macular degeneration and remains part of how inherited eye disease risk is studied today.